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Recombinant EDA or Sonic Hedgehog Rescue
the Branching Defect in Ectodysplasin A
Pathway Mutant Salivary Glands In Vitro
K.L. Wells,1 C. Mou,2 D.J. Headon,2 and A.S. Tucker1*
Hypohidrotic ectodermal dysplasia (HED) is characterized by defective ectodermal organ development.
This includes the salivary glands (SGs), which have an important role in lubricating the oral cavity. In
humans and mice, HED is caused by mutations in Ectodysplasin A (Eda) pathway genes. Various pheno-
types of the mutant mouse EdaTa/Ta, which lacks the ligand Eda, can be rescued by maternal injection or
in vitro culture supplementation with recombinant EDA. However, the response of the SGs to this treat-
ment has not been investigated. Here, we show that the submandibular glands (SMGs) of EdaTa/Ta mice
exhibit impaired branching morphogenesis, and that supplementation of EdaTa/Ta SMG explants with
recombinant EDA rescues the defect. Supplementation of EdardlJ/dlJ SMGs with recombinant Sonic hedge-
hog (Shh) also rescues the defect, whereas treatment with recombinant Fgf8 does not. This work is the
ﬁrst to test the ability of putative Eda target molecules to rescue Eda pathway mutant SMGs. Developmen-
tal Dynamics 239:2674–2684, 2010. VC 2010 Wiley-Liss, Inc.
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INTRODUCTION
Mutations in Ectodysplasin A (Eda)
pathway genes cause hypohidrotic
ectodermal dysplasia (HED). Ectoder-
mal dysplasia encompasses a group of
disorders characterized by defective
development of ectodermally derived
structures such as the hair, teeth, and
exocrine glands (Clarke et al., 1987).
EDA encodes the tumor necrosis fac-
tor (TNF) -like ligand EDA A1 (Sri-
vastava et al., 1997). EDA A1 signals
by means of its receptor EDAR and an
intracellular adaptor protein EDAR-
ADD (Headon et al., 2001), and is
thought to instigate downstream acti-
vation of NFkB (Kumar et al., 2001).
EDA can also undergo alternative
splicing to produce EDA-A2 (Srivas-
tava et al., 1997), although the biolog-
ical function of this splice variant is
unknown. Recessive mutations in
EDA are responsible for X-linked
HED, the most common form of HED
(Kere et al., 1996), while dominant
and recessive mutations in EDAR and
EDARADD have been found in fami-
lies carrying autosomal HED (Mon-
real et al., 1999; Headon et al., 2001).
The spontaneous mouse mutants
EdaTa/Ta, EdardlJ/dlJ, and Edar-
addCr/Cr (Srivastava et al., 1997;
Monreal et al., 1999; Headon et al.,
2001) exhibit a similar phenotype to
human HED in that the hair, teeth,
and exocrine glands are impaired
(Falconer et al., 1951; Gru¨neberg,
1965, 1971; Claxton, 1967; Blecher
et al., 1983). The role of Eda signaling
in hair and tooth development are
thriving areas of research, whereas
research into the role of Eda signaling
in exocrine gland development, in
particular that of the salivary glands
(SGs), is relatively neglected and war-
rants further investigation.
SGs have an important role in pro-
viding lubrication for digestion and
protection of the oral cavity. HED
patients demonstrate reduced whole
saliva ﬂow (Nordgarden et al., 2001)
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leading to xerostomia (dry mouth),
further damage to an already compro-
mised dentition and a reduced quality
of life. Mammals have three pairs of
major SGs that produce approxi-
mately 90% of total saliva (reviewed
in Tucker, 2007): the submandibular
(SMG) and sublingual (SLG) glands,
situated under the tongue with ducts
secreting into the ﬂoor of the mouth,
and the parotid at the back of the
mouth in between the upper and
lower jaw, with ducts secreting saliva
into the inner cheek.
Of the various SG types, the murine
SMG is the most studied and its de-
velopment has been depicted in stages
(Jaskoll and Melnick, 1999). The
developing SMG consists of ectoder-
mally derived epithelial branches
enclosed within a capsule of cranial
neural crest derived mesenchyme
(Jaskoll et al., 2002). The SMG is ﬁrst
visible at embryonic day (E) 11.5 (pre-
bud stage) appearing as a thickening
of the oral epithelium next to the
tongue. By E12.5 (initial bud stage),
the epithelial thickening has protruded
into the underlying mesenchyme,
forming a bud that proliferates and
undergoes branching morphogenesis to
form several branches by E14.5 (pseu-
doglandular stage). Lumina begin to
form in the presumptive ducts and end
buds (the presumptive acini) at
approximately E15.5 (canalicular
stage), and the ﬁrst secretory product
can be detected from around E17.5
(terminal differentiation stage; Mel-
nick and Jaskoll, 2000).
Eda is expressed in the mesen-
chyme and Edar in the epithelium of
the developing SMG at E13 and E14
(Pispa et al., 2003), although the
expression of Edaradd has not been
described. In EdaTa/Ta and EdardlJ/dlJ
adults, the SMGs are hypoplastic with
a reduced number of ductal and aci-
nar structures (Blecher et al., 1983;
Jaskoll et al., 2003). Regarding the
developmental origin of this pheno-
type, the classical study of gland de-
velopment in EdaTa/Ta states that the
embryonic SMGs are unaffected (Gru¨-
neberg, 1971), but it has been
reported recently that EdaTa/Ta
SMGs exhibit reduced branching and
developmental delay from E13 (Mel-
nick et al., 2009). Here, we provide an
analysis of EdaTa/Ta and wild-type
(WT) littermate SMGs to build on this
data. We also study the SMGs of
embryos heterozygous for Eda muta-
tion, as female EdaTa/þ carriers ex-
hibit defective tooth development,
particularly in the upper jaw (Charles
et al., 2009).
Rescue of aspects of the EdaTa/Ta
phenotype has been achieved using
several methods. Transgenic overex-
pression of Eda A1 driven by the
CMV promoter leads to the rescue of
the EdaTa/Ta hair and sweat gland
phenotypes as well as hypodontia
(Srivastava et al., 2001). Similarly,
expression of an Eda A1 transgene in
a tetracycline regulated conditional
mouse model rescued sweat glands
and hair development in EdaTa/Ta,
but the developmental timing of
transgene activation is crucial and
speciﬁc for each organ (Cui et al.,
2009). Injection of a recombinant form
of EDA A1 given to pregnant EdaTa/
Ta mice in a series beginning at E11
leads to the almost complete rescue of
the organs affected in the developing
embryos (Gaide and Schneider, 2003),
although the effect on the SGs was
not documented. In vitro, supplemen-
tation of EdaTa/Ta skin cultures with
recombinant EDA A1 rescues hair
placode development (Mustonen
et al., 2004), while EDA A1 addition
to WT SMG cultures increases
branching and enhances NFkB acti-
vation (Jaskoll et al., 2003). It follows
that it may be possible to rescue
EdaTa/Ta SMGs in culture by recombi-
nant EDA A1 supplementation, and
here we show that this is achievable
during both early and later branching
morphogenesis, an encouraging ﬁnd-
ing for future attempts to correct SG
defects in HED patients.
Recent years have seen consider-
able progress in identifying the genes
regulated by Eda signaling. Notably,
treatment of embryonic EdaTa/Ta skin
cultures with recombinant EDA A1
results in rapid and signiﬁcant up-
regulation of Shh (Pummila et al.,
2007). Furthermore, recent quantita-
tive polymerase chain reaction
(qPCR) proﬁling has revealed down-
regulation of Shh in EdaTa/Ta SMGs
in comparison with WT SMGs (Mel-
nick et al., 2009). We have sought to
build on these data by testing the
ability of exogenous Sonic hedgehog
(Shh) to rescue Eda pathway mutant
SMGs in vitro. We ﬁnd that
supplementation of EdardlJ/dlJ SMGs
with recombinant Shh rescues the
observed defects, whereas treatment
with recombinant Fgf8, another puta-
tive Eda target found to be signiﬁ-
cantly down-regulated in EdaTa/Ta
SMGs (Melnick et al., 2009), does not
rescue the glands.
RESULTS
Edar and Edaradd Are
Expressed From the Earliest
Stages of SMG Development
The expression of Eda and Edar has
been investigated at E13 and E14 in
the SMGs (Pispa et al., 2003), but
expression during the earliest stages
of SMG development has not been
studied, nor has Edaradd expression
been assessed at any stage. Therefore,
we investigated the expression of Eda
pathway genes at early stages of SMG
development by in situ hybridization,
concentrating on the expression of
Edar and Edaradd, because the
expression of these genes likely
reﬂects the location at which the
pathway is acting. At E11.5, Edar
was found to be strongly expressed in
the oral epithelial thickenings of the
developing SMG and in the develop-
ing SMG bud at E12.5 (Fig. 1A,B).
Edaradd expression was also conﬁned
to the epithelium of the developing
SMG from E12.5–E15.5 (Fig. 1C–F).
EdaTa/Ta and EdaTa/1 SMGs
Exhibit Abnormal Branching
Morphogenesis In Vitro
EdaTa/Ta adult SMGs are hypoplastic
with reduced ducts and acini (Blecher
et al., 1983; Jaskoll et al., 2003). To
determine the embryonic stage at
which this defect originates, we chose
to assess the mutant glands after
dissection rather than in histological
sections to evaluate the size and mor-
phology of the glands accurately.
E13.5 WT, EdaTa/þ, and EdaTa/Ta lit-
termate SMGs (n ¼ 35 pairs in total
from 3 litters) were examined, and we
found no signiﬁcant difference in
branch number between any of the
genotypes at this stage. However, we
found a high level of morphological
variation among the EdaTa/Ta SMGs,
and were able to deﬁne 3 morphotypes
based on developmental stage and
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number of branches (Fig. 2A–C). Al-
though WT SMGs demonstrated mild
variability, and of a level normally
expected in litters of WT embryos, we
observed a much wider dispersion of
EdaTa/Ta SMGs with respect to their
branch number (Fig. 2D). WT and
EdaTa/Ta SMGs within the same litter
regularly fell into the same morphotype
group and were indistinguishable from
each other in terms of size and branch
number (compare Figs. 3A and 3B, ﬁrst
panels from left). This indicates that
EdaTa/Ta and EdaTa/þ SMGs exhibit
high morphological variation in compar-
ison with their WT littermates and
that, at this stage of development, it is
unfeasible to attempt to identify an
Fig. 1.
Fig. 1. Edar and Edaradd are expressed
from the earliest stages of submandibular
gland (SMG) development. 35S in situ hybrid-
ization of Edar (A,B) and Edaradd (C–G) on
frontal sections. A: Embryonic day (E) 11.5
oral cavity, showing Edar expression in the
presumptive SMG epithelial thickenings
(arrows). B: E12.5 oral cavity. Edar is
expressed in the SMG epithelial buds
(arrows). C: E12.5 oral cavity, showing Edar-
add expression in the SMG epithelial buds
(arrows). D–F: Edaradd expression in the SMG
epithelial branches at E13.5 (D), E14.5 (E), and
E15.5 (F). t, tongue; p, roof of nasal passage.
Scale bar ¼ 200 mm in A (applies in A–C,E,F);
100 mm in D.
Fig. 2. Embryonic day (E) 13.5 EdaTa/Ta submandibular glands (SMGs) and sublingual glands (SLGs) exhibit high morphological variation. A–C: E13.5
EdaTa/Ta SMG/SLGs from the same litter representative of three morphotypes defined by developmental stage and branch number. A: E13.5 bud mor-
photype. SMG outlined in red. B: E13.5 intermediate morphotype indicating cleft formation, which is absent in A. SLG is outlined in white. C: E13.5
Pseudoglandular morphotype with development of distinct SMG branches in comparison to (B). D: Box and whisker plot showing dispersion of branch
number data for E13.5 SMGs from the three genotype groups. The interquartile range (indicated by box) of the EdaTa/Ta group of SMGs is wider than
that of the WT group, indicating greater variability in E13.5 EdaTa/Ta SMG branch number compared with WTs. Scale bar in A (for A–C) ¼ 200 mm.
D
ev
el
op
m
en
ta
l D
yn
am
ic
s
2676 WELLS ET AL.
Fig. 3. Embryonic day (E) 13.5 EdaTa/Ta submandibular glands (SMGs) exhibit defective branching morphogenesis. A,B: Stage matched E13.5
wild-type (WT; A) and EdaTa/Ta (B) SMGs from littermate embryos cultured for 72 hr. After 24 hr, EdaTa/Ta SMGs exhibit visibly less branching when
compared with WTs, and a similar trend is evident at 48 and 72 hr. C: High magnification of dashed box in (A þ24 hr) showing cleft formation in
WT SMG. D: High magnification of dashed box in (B þ24 hr) showing lack of cleft formation in EdaTa/Ta SMG in comparison to (C). E: Chart show-
ing mean Spooner ratios of WT, EdaTa/þ, and EdaTa/Ta groups at each time point in culture. The Spooner ratio is a measure of branching over time,
calculated by dividing number of buds present on day  by number of buds in the same explant at day 0. Error bars depict one standard error 6
mean. An asterisk denotes statistical significance (unpaired t-test) between EdaTa/Ta and WT means. F: Hematoxylin and eosin-stained wax section
of E15.5 WT SMG. G: Representative EdaTa/Ta SMG (n ¼ 6) stage matched to F. Lumen formation (arrows) is unaffected in the mutant. Scale bar ¼
200 mm in A (applies in A,B), 100 mm in C (applies in C,D) in F (applies in F,G).
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EdaTa/Ta SMG phenotype. Further-
more, Eda appears to be consistently
dispensable for initiation and in many
cases for the early development of the
SMG.
To determine whether Eda signal-
ing plays a role in SMG branching
morphogenesis, we next compared
the development of precisely stage
matched E13.5 WT and EdaTa/Ta lit-
termate SMGs for 72 hr in vitro. We
found that EdaTa/Ta SMGs exhibited
visibly less branching when compared
with WTs. The effect is apparent after
24 hr of culture when the EdaTa/Ta
gland displays less cleft formation
than WTs (Fig. 3A–D). After 72 hr of
development, EdaTa/Ta SMGs had
formed markedly fewer branches in
comparison with stage matched WT
littermates (Fig. 3A,B). This observa-
tion is supported by histological anal-
ysis of E15 WT and EdaTa/Ta SMGs
(Fig. 3F,G). In the WT SMG at E15,
the epithelial branches begin to hol-
low out to form lumen (Fig. 3F); duc-
tal lumen were found to be developing
as normal in the mutant SMGs at
E15 (Fig. 3G), indicating that the
branching defect is not due to overall
developmental delay of the gland.
Traditionally, quantiﬁcation of SMG
branching is achieved by counting the
number of buds present in SMG
explants at a deﬁned time point, and
dividing this by the number of buds
present at the onset of the culture pe-
riod. The result is termed the Spooner
ratio (Spooner and Bassett, 1989) and
gives a measure of the extent of
branching that has taken place in a
particular explant over a deﬁned time
period. To quantify the visible differ-
ences between WT and EdaTa/Ta
SMGs in vitro, mean Spooner ratios
for the WT, EdaTa/þ and EdaTa/Ta
groups were compared at each time
point (Fig. 3E). After 24 hr in culture,
EdaTa/Ta SMGs exhibited a 38% lower
Spooner ratio than WTs. Subsequently
the branching defect was not recovered,
with EdaTa/Ta SMGs exhibiting a signiﬁ-
cant 41% lower Spooner ratio than WTs
at 48 hr. This indicates that the phe-
notype observed in EdaTa/Ta SMGs
stems from an early defect in branch-
ing morphogenesis. Of interest, the
EdaTa/þ SMGs followed a similar de-
velopmental trend to the EdaTa/Ta
SMGs; mean Spooner ratios for the
EdaTa/þ group were not signiﬁcantly
different from the EdaTa/Ta SMG
group at any time point (Fig. 3E).
Recombinant EDA A1
Rescues Branching in EdaTa/Ta
SMGs In Vitro
Recombinant EDA A1 supplementa-
tion rescues primary hair follicle de-
velopment in EdaTa/Ta skin explants
(Mustonen et al., 2004). We attempted
to rescue the branching defect identi-
ﬁed in embryonic EdaTa/Ta and
EdaTa/þ SMGs by EDA A1 supple-
mentation in vitro. E13.5 SMGs were
initially selected because this stage
precedes the appearance of the
branching defect. We chose to supple-
ment the glands with 100 ng/ml EDA
A1 because this concentration rescues
primary hair placode development in
EdaTa/Ta skin in vitro (Mustonen
et al., 2004).
Before attempting SMG rescue
experiments, it was necessary to test
our batch of EDA A1 to conﬁrm func-
tionality. Dorsal skin explants from
E13.5 EdaTa/Ta embryos were treated
with EDA A1 for 24 hr to rescue pri-
mary hair placodes, which do not de-
velop in EdaTa/Ta (Mustonen et al.,
2004; Mou et al., 2006). While pri-
mary hair placodes, as detected by
Shh expression, remained absent in
untreated EdaTa/Ta skin, rescued
placodes were detected in EDA A1-
treated EdaTa/Ta skins (Supp. Fig.
S1A–C, which is available online). For
the SMG rescue experiments, EdaTa/Ta
SMGs from the same embryo were re-
served in pairs. From each pair, one
SMG was treated with 100 ng/ml EDA
A1 and its counterpart from the same
embryo was cultured in the absence of
EDA A1. After 72 hr, E13.5 SMGs sup-
plemented with 100 ng/ml EDA A1
demonstrated visibly augmented
branching (Fig. 4B) compared with
their unsupplemented control pairs
(Fig. 4A) and appeared comparable in
branch number to WT littermate
SMGs (Fig. 4B,C). In fact, more cleft
formation and budding was visible in
the treated glands (Fig. 4E) compared
with their control pairs (Fig. 4D) as
early as 24 hr into the culture period.
Calculation of Spooner ratio and paired
t-test revealed a statistically signiﬁ-
cant 36% (P ¼ 0.02) mean increase in
branching of the supplemented
explants compared with their unsup-
plemented pairs after 24 hr, and an
84% (P ¼ 0.001) mean increase after
48 hr. Comparison of Spooner ratios at
all time points between the WT,
treated, and untreated groups of
glands showed that the branching
defect seen in EdaTa/Ta SMGs was
fully rescued after only 24 hr of supple-
mentation with 100 ng/ml EDA A1
(Fig. 4F). With addition of fresh EDA
A1 daily, the rescue was maintained
with an absence of excess branching or
negative effects for a further 48 hr at
which point the experiment was termi-
nated. Rescue of the branching pheno-
type and an absence of negative effects
was apparent in the treated SMGs
from all morphotype groups, indicating
that EdaTa/Ta SMGs can be treated
with 100 ng/ml EDA A1 from an early
stage of development to achieve rescue.
Recombinant EDA A1-mediated res-
cue of other ectodermal structures
affected by the Eda mutation is highly
stage dependent. To determine
whether the SMGs could be rescued
later in development, E15.5 EdaTa/Ta
SMGs were cultured with 500 ng/ml
EDA A1 (a high concentration to
ensure adequate penetration of the
larger explants). After 24 hr, the EDA
A1-treated explants exhibited a mean
19% greater (P ¼ 0.01, paired t-test)
Spooner ratio compared with their
untreated pairs (Fig. 5A–D). EdaTa/Ta
SMGs, therefore, remain responsive to
exogenous recombinant EDA A1 subse-
quent to the manifestation of the
branching defect, suggesting that the
possibility of recombinant EDA A1-
mediated rescue is not restricted to
early SMG branching morphogenesis.
Recombinant Shh-N Rescues
Branching in EdardlJ/dlJ
SMGs In Vitro
qPCR proﬁling has revealed down-
regulation of Shh in EdaTa/Ta SMGs
in comparison with WT SMGs (Mel-
nick et al., 2009), and treatment of
embryonic EdaTa/Ta skin cultures
with recombinant EDA A1 results in
up-regulation of Shh (Pummila et al.,
2007). We hypothesized that applica-
tion of recombinant Shh to Eda path-
way mutant SMGs explants would
rescue the branching defect. Both
EdaTa/Ta and EdardlJ/dlJ adult SMGs
are characterized by hypoplasia and a
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reduction in acinar and ductal struc-
tures (Jaskoll et al., 2003; data not
shown). For our downstream rescue
experiments, we moved to EdardlJ/dlJ
SMGs. These mice lack functional
Edar, and we considered them the
best system for these experiments
because the possibility of activating
signaling downstream of the Eda
pathway through Edar is abolished.
Before attempting rescue with Shh-
N, it was necessary to conﬁrm activa-
tion of the expected developmental
pathway by Shh-N in our SMG cul-
tures. E13.5 WT SMG explants were
cultured for 24 hr with 1.5 mg/ml Shh-
N, a concentration determined by
dose response experiment to preclude
toxicity on the developing gland (data
not shown) and processed for whole-
mount in situ hybridization of Gli1 or
Fig. 4. 100 ng/ml exogenous recombinant EDA A1 rescues branching in embryonic day (E) 13.5 EdaTa/Ta submandibular glands (SMGs) in vitro.
E13.5 EdaTa/Ta SMG pair (A,B) and E13.5 wild-type (WT) littermate SMG (C) cultured for 72 hr. A,B: Untreated EdaTa/Ta SMG (A), and EdaTa/Ta SMG
(B) from the same embryo as A treated with 100 ng/ml EDA A1. Branching is increased in the treated SMG from 24 hr in comparison with A. C:
WT SMG, littermate of A and B. Branching is comparable to B. D: High magnification of dashed box in (A þ24 hr). E: High magnification of
dashed box in (B þ24 hr) showing increased budding and cleft formation in treated EdaTa/Ta SMG in comparison with D. F: Chart showing mean
Spooner ratios of WT, untreated and 100 ng/ml EDA A1-treated groups at each time point in culture. An asterisk denotes statistical significance
between untreated EdaTa/Ta / EdaTa/þ group and 100 ng/ml-treated group means (unpaired t-test). Error bars depict one standard error 6 mean.
Scale bar ¼ 200 mm in A (applies in A–C), 100 mm in D (applies in D,E).
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Fig. 5. Exogenous EDA A1 rescues branching in embryonic day (E)
15.5 EdaTa/Ta submandibular glands (SMGs) in vitro. E15.5 EdaTa/Ta
SMG pair (n ¼ 6). A: Untreated EdaTa/Ta SMG. B: SMG pair to A treated
with 500 ng/ml EDA A1, showing more branch formation in comparison
to A after 24 hrs. C: High magnification of dashed box in (A þ24 hr). D:
High magnification of dashed box in (B þ24 hr), indicating more branch
formation (arrows) in developing EdaTa/Ta SMG with EDA A1 treatment
in comparison to C. Scale bar ¼ 200 mm in A (applies in A,B), 100 mm
in C (applies in C,D).
Fig. 6.
Fig. 7.
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Ptc1, known transcriptional targets
of Shh signaling (Ingham and
McMahon, 2001). Up-regulation of
both genes was observed in
explants treated with Shh-N (Supp.
Fig. S2A–D). Within the same pe-
riod of color development, control
SMGs showed no signal (Shh path-
way components are normally
expressed at very low levels in the
SMGs). For the rescue experiments,
E13.5 EdardlJ/dlJ SMGs were cul-
tured for 24 hr with 1.5 mg/ml Shh-
N peptide. After 24 hr in culture,
the Shh-N-treated explants exhib-
ited a mean 58% greater (P ¼
0.004, paired t-test) Spooner ratio
compared with their untreated pairs
(Fig. 6), an improved increase in
branching on that achieved by
application of EDA A1 to E13.5
EdaTa/Ta SMGs for 24 hr (36%). Ex-
ogenous Shh is, therefore, sufﬁcient
to rescue the branching phenotype
in EdardlJ/dlJ SMG explants, and
like EDA A1-mediated rescue, is
successful within 24 hr.
Fgf8 is a potential target of Eda sig-
naling in the SMGs, because qPCR
has revealed down-regulation of Fgf8
in EdaTa/Ta SMGs (Melnick et al.,
2009). We tested whether application
of exogenous Fgf8 was sufﬁcient to
rescue EdardlJ/dlJ SMGs in a similar
manner to EDA A1 and Shh. E13.5
EdardlJ/dlJ SMGs were treated with
200 ng/ml Fgf8, a concentration
shown by Jaskoll et al. (2004b) to
increase branching in WT SMG
explants after 72 hr in culture. After
24 hr in culture, we observed no dif-
ference in branch number between
our Fgf8-treated EdardlJ/dlJ SMGs
and their untreated pairs (Fig. 7). We
allowed some of the explants to con-
tinue to develop for a further 48 hr
and found no change in branch num-
ber in response to Fgf8 treatment,
although we noticed that the treated
explants appeared larger overall than
their untreated pairs (Fig. 7A,B). We
quantiﬁed this by measuring the sur-
face area of the epithelial portion of
the explant, and dividing this value
by branch number, to give a mean
surface area per end bud. We found
that the buds in the Fgf8-treated
explants were a mean 24% larger
than those of their untreated pair
explants (P ¼ 0.007, paired t-test; Fig.
7C). Fgf8 application alone is, there-
fore, not sufﬁcient to rescue branch-
ing in EdardlJ/dlJ SMGs, but appears
to increase end bud size.
DISCUSSION
Eda Signaling Is Required for
Normal SMG Branching
Morphogenesis
Analysis of the expression of Edar
and Edaradd revealed that these key
constituents of the Eda pathway are
expressed from the earliest stages of
SMG development—earlier than pre-
viously reported. Edar is expressed in
the thickening and budding oral epi-
thelium of the developing SMG,
which in terms of the location of
expression agrees with the work of
Pispa et al. (2003) who demonstrated
Edar expression in the epithelium of
the branching SMG at E13 and E14.
In the present work, the expression of
Edaradd is investigated for the ﬁrst
time in the developing SMG, and is
shown to be conﬁned to the epithe-
lium from early stages of development
through branching morphogenesis.
The expression of Edaradd mirrors
that of Edar, suggesting that Edar-
add interacts with Edar in the devel-
oping SMGs as in other ectodermal
organs such as the tooth and hair fol-
licles (Headon et al., 2001).
Given that the Eda pathway is
expressed from the earliest stages of
SMG development, it was reasonable
to expect the appearance of a defect
early in the development of the SMG.
We show that E13.5 EdaTa/Ta SMGs
in fact exhibit high morphological var-
iation in comparison with their WT
littermates. This variability is not
surprising given that a similar phe-
nomenon exists with respect to the
EdaTa/Ta tooth phenotype; the cusp
morphology of the teeth is variable,
and the third molar is missing in
some but not all cases (Gru¨neberg,
1967). The palatal rugae of EdaTa/Ta
mice have also been shown to exhibit
high phenotypic variability in com-
parison with WTs (Charles et al.,
2007). A similar high variability in
the EdaTa/Ta SMG may explain why
the original studies by Gru¨neberg
(1971) found that the embryonic
major SGs were unaffected, whereas
results from Melnick et al. (2009)
show that the EdaTa/Ta SMG is char-
acterized by hypoplasia and develop-
mental delay from E13.
Our analyses of E13.5 EdaTa/Ta
SMGs and their WT littermates in
culture show that the pathway is not
required for initiation of the SMGs;
rather the overarching defect is a fail-
ure of normal branching morphogene-
sis, conﬁrmed by our observations of
the development of stage matched
EdaTa/Ta and WT littermate SMGs in
vitro. The concept that the SMGs do
not require Eda signaling at an early
stage of development ﬁts with data
from other ectodermal organs; the
tooth and secondary/tertiary hair fol-
licles, despite their abnormal develop-
ment in the absence of Eda signaling,
do not require Eda signaling for
Fig. 6. Exogenous Sonic hedgehog (Shh) rescues branching in EdardlJ/dlJ submandibular glands (SMGs) in vitro. Embryonic day (E) 13.5 EdardlJ/
dlJ SMG pair (n ¼ 5). A: Control EdardlJ/dlJ SMG. B: SMG pair to A treated with 1.5 mg/ml Shh-N, showing more branch formation in comparison
to (A) after 24 hrs. C: High magnification of dashed box in (A þ24 hr). D: High magnification of dashed box in (B þ24 hr), indicating more cleft and
branch formation in comparison to C. E: Chart showing mean Spooner ratios of untreated and 1.5 mg/ml Shh-N-treated groups after 24 hr in cul-
ture. Significance measured by paired t-test. Error bars depict one standard error 6 mean. Scale bar ¼ 200 mm in A (applies in A,B), 100 mm in C
(applies in C,D).
Fig. 7. Exogenous Fgf8 does not rescue branching in EdardlJ/dlJ submandibular glands (SMGs) in vitro. Embryonic day (E) 13.5 EdardlJ/dlJ SMG
pair (n ¼ 5). A: Control EdardlJ/dlJ SMG. B: SMG pair to A treated with 200 ng/ml Fgf8b, indicating enlargement of explant at 48 hr in comparison
with A. SMG and SLG epithelium outlined by dotted line at E13. C: Chart showing mean single bud size of control and Fgf8-treated explants after
48 hr in culture. Significance measured by paired t-test. Error bars depict one standard error 6 mean. Scale bar ¼ 200 mm in A (applies in A,B).
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initiation (Pispa et al., 1999; Tucker
et al., 2000; Laurikkala et al., 2002).
These data, along with the present
work, suggest some redundancy of the
pathway. The TNF receptor Troy acts
redundantly with Edar in secondary
hair follicle development (Pispa et al.,
2008) and it would be interesting to
investigate the role of Troy in SMG
development. We also show that em-
bryonic EdaTa/Ta and EdaTa/þ SMGs
exhibit a similar branching defect. It
can be hypothesized that the X-chro-
mosome inactivation effect in female
heterozygous carriers of the X-linked
Eda mutation leads to a reduced
level of Eda availability in EdaTa/þ
SMGs in comparison with WTs.
This difference in expression level
appears to have great consequences in
SMG development, and this idea ﬁts
with data showing that human female
carriers of XL-HED exhibit reduced
saliva ﬂow (Lexner et al., 2007).
EdaTa/Ta SMGs Can Be
Rescued With Recombinant
EDA A1 In Vitro
Supplementation of E13.5 EdaTa/Ta
SMGs with 100 ng/ml EDA A1 results
in rescue of the branching phenotype
after 24 hr, with EDA A1 supplemen-
tation bringing about increased epi-
thelial clefting and branch elongation.
This agrees with data showing that
exogenous EDA A1 applied to E14
WT SMGs in culture increases
branching (Jaskoll et al., 2003). We
also show that recombinant EDA A1-
mediated rescue is achievable later in
branching morphogenesis at E15.5.
Recombinant EDA A1-mediated res-
cue of other ectodermal structures
affected by Eda mutation is highly
stage dependent. For example, in
experiments whereby the EdaTa/Ta
phenotype was rescued by maternal
injection of recombinant EDA A1,
molar morphogenesis could only be
fully rescued by injections adminis-
tered from early in development
(Gaide and Schneider, 2003). Our
results show that the developing
SMGs, unlike the developing teeth,
are still able to respond to EDA A1
supplementation after the appearance
of the EdaTa/Ta phenotype, an encour-
aging ﬁnding for future attempts to
correct SG defects in HED patients.
EdardlJ/dlJ SMGs Can Be
Rescued With Exogenous
Shh In Vitro
Shh signaling is essential for SMG de-
velopment; the SMGs of Shh/
embryos do not develop beyond the
onset of branching morphogenesis,
and cyclopamine treatment of WT
SMG explants results in less branch-
ing (Jaskoll et al., 2004a). Here, we
show that exogenous Shh is sufﬁcient
to rescue the branching phenotype in
EdardlJ/dlJ and can do so in the same
time scale as EDA A1. We cannot dis-
count the possibility that Shh-medi-
ated rescue of EdardlJ/dlJ SMGs takes
place by means of a mechanism inde-
pendent of signaling downstream of
Eda. However, taken together with
previous studies showing that treat-
ment of embryonic EdaTa/Ta skin cul-
tures with recombinant EDA A1
results in up-regulation of Shh (Pum-
mila et al., 2007) and that Shh is
down-regulated in EdaTa/Ta SMGs
(Melnick et al., 2009), our results pro-
vide strong additional evidence that
Shh is an important downstream tar-
get of Eda signaling in the SMGs.
EdaTa/Ta mice lack primary hair fol-
licles, yet treatment of EdaTa/Ta skin
cultures with exogenous Shh does not
rescue their initiation (Pummila
et al., 2007), consistent with a later
role for Shh in skin appendage devel-
opment. In some cases, however, Shh
overexpression is associated with tumor
formation in the skin (Oro et al., 1997).
In our experiments, the morphology of
SMGs treated with Shh appeared nor-
mal, with no indication of ectopic SMG
formation or tumorigenesis. Therefore,
our results are also consistent with a
role for Shh in later stage development
of ectodermal appendages.
qPCR data have indicated that Fgf8
is a target of Eda signaling in the
SMGs (Melnick et al., 2009). We were
unable to demonstrate rescue of
EdardlJ/dlJ SMG explants by Fgf8
supplementation, although we observed
an increase in gland size. In embryonic
EdaTa/Ta tooth explants, cusp morpho-
genesis is partially rescued by exoge-
nous Fgf10 (Pispa et al., 1999),
although it is unclear whether this is
through a mechanism normally inde-
pendent of Eda signaling, such as an
increase in epithelial proliferation. It is
possible that the effects we observed on
Fgf8 supplementation of EdardlJ/dlJ
SMGs are due to a similarly general-
ized increase in proliferation, but it also
seems plausible that Fgf8 is unable to
act alone in the formation of branches
and requires other factors for normal
morphogenesis. It seems likely that
Eda signaling controls a variety of dif-
ferent transcriptional targets in the
SMGs, and future work which identiﬁes
how these different factors act in con-
cert to control branching morphogene-
sis will be of interest.
EXPERIMENTAL
PROCEDURES
Animals
All Eda pathway mutant mice were on
the FVB/N background. E13.5 WT,
EdaTa/þ, and EdaTa/Ta embryos were
obtained from EdaTa/þ females
crossed with EdaTa/Y males. E13.5
EdardlJ/dlJ and EdardlJ/þ embryos
were obtained from EdardlJ/þ females
crossed with EdardlJ/dlJ males. E15
EdaTa/Ta, EdardlJ/dlJ, and Edar-
addCr/Cr embryos were obtained from
homozygous females crossed with
hemi-/homozygous males. In the text,
EdaTa/Ta refers to EdaTa/Ta females
and EdaTa/Y males: EdardlJ/dlJ and
EdaraddCr/Cr refer to homozygous
animals. CD1 mice were bred to obtain
stage matched control embryos where
required. Pregnant females were
killed by cervical dislocation and noon
on the day of discovery of the vaginal
plug was designated day 0.5 of devel-
opment. Embryos were harvested,
staged according to Theiler (1989) and
decapitated in phosphate buffered sa-
line (PBS) for immediate ﬁxation, or in
complete culture medium (Advanced
Dulbecco modiﬁed Eagle’s minimal
essential medium F-12 [DMEM-F12;
Gibco, Invitrogen] supplemented with
1% penicillin/streptomycin and 1%
Glutamax [Gibco, Invitrogen]) for
organ culture experiments.
Genotyping
DNA was extracted by digestion of
tail snip tissue in 0.5 mg/ml protein-
ase K at 55C overnight, followed by
phenol chloroform puriﬁcation and
ethanol precipitation. Genotype of
E13.5 WT, EdaTa/þ and EdaTa/Ta
embryos was identiﬁed by PCR analy-
sis using primer sets speciﬁc for Eda
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(covering the exon 1 region deleted in
EdaTa/Ta that failed to generate a
product from Eda mutant DNA), Y
chromosome, and Actin (for positive
control). Primer sequences were as
follows: EDA: 50-AGGACAGTAGTC-
GCCTGT-30 (forward), 50-GCCGCCG-
CCCTTCCTAGG-30 (reverse); Y chro-
mosome: 50-CTGGAGCTCTACAGTG-
ATGA-30 (forward), 50-CAGTTACCA-
ATCAACACATCAC-30 (reverse); Actin:
50-GCTTCTGAGATGTCTCTCTCT-30
(forward), 50-ACACAGGCTTTTGTA-
GGTTGC-30 (reverse). These primers
generated 509 bp (Eda), 343 bp (Y chro-
mosome), and 159 bp (Actin) fragments.
The Edar mutant animals used in
this study were of the downlessJackson
strain which possess a recessive G to
A point mutation within the Edar
death domain (Headon and Overbeek,
1999). Genotype of E13.5 EdardlJ/dlJ
and EdardlJ/þ embryos was deter-
mined by PCR analysis using Edar-
speciﬁc primers, the forward primer
containing a one nucleotide mismatch
from the template DNA. The mis-
match enabled the generation of a
TaqI restriction site unique to the WT
sequence. Primer sequences were 50-
TGAAAACATGGCGCCACCTTGTC-30
(forward, mismatch underlined), 50-
TCACTCACAGCTGTCGGTCGTG-30
(reverse). These primers generated a
309-bp product. Overnight restriction
of EdardlJ/dlJ product with TaqI
(Sigma) at 65C resulted in 142-bp
and 167-bp fragments (due to a natu-
ral TaqI site within the PCR product),
whereas restriction of EdardlJ/þ prod-
uct resulted in fragments of 167 bp,
142 bp, 120 bp, and 22 bp. Fragments
were visualized on a 3% agarose gel.
The mismatch primer was designed
using dCAPS Finder 2.0 online
software.
PCR cycling conditions were: 94C
2 min 30 s, 94C 30 s, 54C 30 s, 72C
1 min for 36 cycles.
Tissue Processing and
Sectioning
Tissues were ﬁxed in 4% paraformal-
dehyde at 4C overnight and washed
in PBS before dehydration in a meth-
anol and isopropanol series, and
clearing in 1,2,3,4-tetrahydronaph-
thalene. Cleared samples were incu-
bated in parafﬁn wax at 65C before
embedding in moulds. Sections were
cut to a thickness of 8 mm, mounted
on glass slides (Superfrost Plus, VWR
International) and dried on a 42C
hotblock overnight.
In Situ Hybridization
Radioactive in situ hybridization of
35S-UTP-labeled Edar and Edaradd
probes was performed as described in
Tucker et al. (1999). Edar was linear-
ized with Bss HI and transcribed with
T7. Edaradd was linearized with Spe
1 and transcribed with T3. Sections
were counterstained with methyl
green and photographed under dark-
ﬁeld.
Whole-mount in situ hybridization
of digoxigenin-labeled Ptc1 and Gli1
probes was performed according to
Wilkinson (1995). For reliable com-
parison of expression levels between
treated and control glands, explants
were subjected to simultaneous and
identical processing and color devel-
opment. Color was developed for 5 hr
(when a strong signal became appa-
rent in Shh-N-treated explants)
before photographing. Three explants
were processed per treatment group
and probe, and all explants within
each group showed similar results.
Gli1 was linearized with NotI and
transcribed with T3. Ptc1 was linear-
ized with Bam HI and transcribed
with T3.
Whole-mount in situ hybridization
of a digoxigenin-labeled Shh probe on
skin explants was performed as
described in Mou et al. (2006).
Histology Staining
Sections were cleared with Histoclear,
rehydrated through an ethanol series
and washed in dH2O. Sections were
stained with hemotoxylin and eosin
(H&E) and differentiated in acid alco-
hol. After staining, sections were
washed in dH2O, dehydrated through
an ethanol series, cleared in xylene
and coverslipped with DPX mounting
medium.
Organ Culture
SMGs were dissected in complete cul-
ture medium and reserved in pairs to
compare control and treated glands
from the same embryo. Explants were
mounted on membranes (BD Falcon
cell culture inserts) and ﬂoated over
culture medium in glass bottom
dishes (MatTek Corporation). Medium
for experimental explants was supple-
mented with recombinant Fc-EDA A1
(Gaide and Schneider, 2003), Fgf8b,
or Shh-N peptide (R&D Systems).
Explants were cultured in a 37C, 5%
CO2 incubator, photographed and the
medium changed daily. Skin explant
cultures to conﬁrm recombinant
EDA-A1 functionality were performed
as described in Mou et al. (2006).
Morphometric Analysis
The Spooner ratio (number of
branches present at  hr/number of
branches present at 0 hr) (Spooner
and Bassett, 1989) was calculated for
each SMG by manually counting
branch number using an image of the
explant in WCIF ImageJ 1.37c. The
Spooner ratios of treated and
untreated explants from the same
embryo were compared by paired t-
test, and mean Spooner ratios for
groups of explants were compared by
unpaired t-test. Two-dimensional sur-
face areas were calculated using an
image of the explant in Image Pro 6.2:
the polygon tool was used to draw
carefully around the epithelial por-
tion of the SMG (excluding main
duct) and scale bars used to convert
the surface area in pixels of the re-
sultant shape to mm2. Data were ana-
lyzed and converted to charts using
Microsoft Ofﬁce Excel 2007. Box plots
were constructed using Graphpad
Prism 5. Statistically, the level of sig-
niﬁcance was taken as P < 0.05.
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